PAR-13-025 in Selected Topics in Transfusion Medicine open until January 2017

PAR-13-002 for Clinical Trial Pilot Studies

PAR-13-128 for Multicenter Phase III Clinical Trials

NHLBI PAR-13-026 (R01)

NHLBI PAR-13-025 (R21)

NHLBI PAR-10-005 (R34) Clinical Trial Pilot Studies

The Clinical Trials Development Resource for Hematologic Disorders (U24)

NHLBI Ancillary Studies in Clinical Trials (R01) – RFA-HL-13-003

NHLBI PAR (R21) for secondary dataset analyses

PAR 10-096 NHLBI Investigator-Initiated Multisite Clinical Trials (Collaborative R01)

PAR-10-234: Bioengineering Research Partnerships (BRP)[R01]

PA-10-009: Bioengineering Research Grants (BRG)[R01]

PA-10-010: Exploratory/Developmental Bioengineering Research Grants(EBRG) [R21]

BARDA CBRN BAA-12-100-SOL-00011: A Broad Agency Announcement (BAA) for advanced development of therapies for hematopoietic syndrome, bone marrow stromal cell loss, and vascular injury resulting from acute exposure to ionizing radiation


CLICK HERE to view NHLBI presentation “Supporting a Strategic Research Agenda in Transfusion Medicine” .